U.S. demand for menopause hormone therapy more than doubles
Menopause hormone therapy is seeing sharply higher use in the United States, according to a study based on a national pharmacy database. Among women aged 40 to 74, use of the treatment more than doubled between 2023 and 2026.
The findings indicate a substantial increase in demand for menopause treatments during the three-year period. The database analysis measures changes in use, but does not by itself explain what is driving the increase.